ArticleJournal of translational medicine2024

RBM8A, a new target of TEAD4, promotes breast cancer progression by regulating IGF1R and IRS-2.

Fang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.